126 related articles for article (PubMed ID: 10023085)
1. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems.
Kranendonk M; Fisher CW; Roda R; Carreira F; Theisen P; Laires A; Rueff J; Vermeulen NP; Estabrook RW
Mutat Res; 1999 Feb; 439(2):287-300. PubMed ID: 10023085
[TBL] [Abstract][Full Text] [Related]
2. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
3. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines.
Duarte MP; Palma BB; Laires A; Oliveira JS; Rueff J; Kranendonk M
Mutagenesis; 2005 May; 20(3):199-208. PubMed ID: 15843388
[TBL] [Abstract][Full Text] [Related]
5. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
[TBL] [Abstract][Full Text] [Related]
7. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
[TBL] [Abstract][Full Text] [Related]
8. Expression of recombinant human cytochrome P450 1A2 in Escherichia coli bacterial mutagenicity tester strain.
Chun YJ
Arch Pharm Res; 1998 Jun; 21(3):305-9. PubMed ID: 9875448
[TBL] [Abstract][Full Text] [Related]
9. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase.
Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y
Mutat Res; 1999 Jun; 442(2):113-20. PubMed ID: 10393280
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
Josephy PD; Evans DH; Parikh A; Guengerich FP
Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-throughput genotoxicity assay using Umu test strains expressing human cytochrome P450s and NADPH-P450 reductase and bacterial O-acetyltransferase.
Hori H; Hirata D; Fujii W; Oda Y
Environ Mol Mutagen; 2017 May; 58(4):209-216. PubMed ID: 28436560
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
[TBL] [Abstract][Full Text] [Related]
14. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108.
Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T
Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669
[TBL] [Abstract][Full Text] [Related]
15. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
[TBL] [Abstract][Full Text] [Related]
16. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
[TBL] [Abstract][Full Text] [Related]
17. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
18. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
Kang IH; Kim HJ; Oh H; Park YI; Dong MS
Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
[TBL] [Abstract][Full Text] [Related]
19. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase.
Cooper MT; Porter TD
Mutat Res; 2000 Nov; 454(1-2):45-52. PubMed ID: 11035158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
